| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 20 |
| 1 | ACETAMINOPHEN | 19 |
| 2 | LAMOTRIGINE | 18 |
| 3 | ACETAMINOPHEN 500MG | 15 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 5 | PAIN RELIEVER | 15 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 14 |
| 7 | METHYLPREDNISOLONE | 14 |
| 8 | METOPROLOL TARTRATE | 14 |
| 9 | DIPHENHYDRAMINE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIBACTERIAL HAND WIPES | 11 | 0.0329 |
| 1 | BENZALKONIUM CHLORIDE 0.13% | 11 | 0.0293 |
| 2 | BENZALKONIUM CHLORIDE | 11 | 0.0251 |
| 3 | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% | 2 | 0.0192 |
| 4 | APRACLONIDINE | 2 | 0.0180 |
| 5 | HYALURONATE SODIUM | 8 | 0.0052 |
| 6 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 7 | FLUOROMETHOLONE | 12 | 0.0037 |
| 8 | TOBRAMYCIN AND DEXAMETHASONE | 12 | 0.0036 |
| 9 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 1 | Corticosteroid [EPC] | 28 |
| 2 | Prostaglandin Analog [EPC] | 22 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 21 |
| 4 | Anti-epileptic Agent [EPC] | 20 |
| 5 | Mood Stabilizer [EPC] | 19 |
| 6 | Aminoglycoside Antibacterial [EPC] | 13 |
| 7 | Alkylating Drug [EPC] | 12 |
| 8 | Standardized Chemical Allergen [EPC] | 11 |
| 9 | Benzodiazepine [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbonic Anhydrase Inhibitor [EPC] | 9 | 0.0004 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Cephalosporin Antibacterial [EPC] | 3 | 0.0003 |
| 3 | Aminoglycoside Antibacterial [EPC] | 13 | 0.0003 |
| 4 | Prostaglandin Analog [EPC] | 22 | 0.0002 |
| 5 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |
| 6 | Anti-epileptic Agent [EPC] | 20 | 0.0001 |
| 7 | Mood Stabilizer [EPC] | 19 | 0.0001 |
| 8 | Ester Local Anesthetic [EPC] | 4 | 0.0001 |
| 9 | Recombinant Human Nerve Growth Factor [EPC] | 1 | 0.0001 |